Journal of Medicinal Chemistry · 2002 · 38 citations · 12 references
MedicineMedicinal ChemistryPharmacologyMolecular PharmacologyNeurochemistryNeuropharmacologyHeterocyclic ChemistryLigand BindingNeurochemical PharmacologyReceptor PharmacologySerotonergic PharmacologyIndole ChemistryIndole DerivativesIndole SynthesisMelatonin PharmacologyMelatonin PhysiologyMelatonin Receptor PharmacologyNitro CompoundsSelective Binding Sites
The aim of this study was to synthesize selective ligands for melatoninergic subtype receptors that could elucidate the physiological role of melatonin (N-acetyl-5-methoxytryptamine, 1). So, we first investigated the role of a nitro substituent in the 4-, 6-, or 7-position of the indole heterocycle. Comparatively to melatonin, its analogues that nitrated in the 6- or 7-position (6 and 22) lose MT(3) but retain good MT(1) and MT(2) affinities, whereas the 4-nitro isomer (5) shows very high affinity (nanomolar) and selectivity for the MT(3) binding sites. N-Methylation of the indole nucleus of compound 5 potentiates these effects and affords the most potent and selective MT(3) ligand (17). The 2-iodo derivatives (12 and 10) of compounds 5 and 17 have also been synthesized to evaluate their binding profile with a view to further develop MT(3) selective radioligands.
12
Steven M. Reppert, Catherine Godson, C.D. Mahle et al. · Proceedings of the National Academy of Sciences · 1995 · 883 citations
Melatonin mediates two distinct responses in vascular smooth muscle
Suzanne Doolen, Diana N. Krause, M. L. Dubocovich et al. · European Journal of Pharmacology · 1998 · 229 citations